尖峰集团子公司尖峰药业通过药品GMP符合性检查

Core Viewpoint - Jianfeng Group's subsidiary, Zhejiang Jianfeng Pharmaceutical Co., has passed the GMP compliance inspection for its raw material production line of Tafluprost, ensuring the supply capability for Tafluprost eye drops and enriching the company's product line [1] Group 1 - Jianfeng Pharmaceutical has received the GMP compliance inspection result announcement from the Zhejiang Provincial Drug Administration [1] - The successful inspection allows the company to produce Tafluprost raw materials, which is critical for the manufacturing of Tafluprost eye drops [1] - This development enhances the company's product offerings and strengthens its position in the pharmaceutical market [1]